We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+11.72%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
10 Year Est. Return
AUM
$249M
AUM Growth
+$11.2M
Cap. Flow
+$1.58M
Cap. Flow %
0.64%
Top 10 Hldgs %
35.47%
Holding
513
New
48
Increased
266
Reduced
45
Closed
120

Top Buys

Rank Stock Value
1
IQ icon
iQIYI
IQ
+$7.05M
2
AMZN icon
Amazon
AMZN
+$3.89M
3
QURE icon
uniQure
QURE
+$2.86M
4
BNTX icon
BioNTech
BNTX
+$2.81M
5
DXCM icon
DexCom
DXCM
+$2.78M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$5.6M
2
PG icon
Procter & Gamble
PG
+$3.27M
3
NVO
Novo Nordisk
NVO
+$3.16M
4
CVS icon
CVS Health
CVS
+$3.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.85M

Sector Composition

Rank Sector Weight
1 Technology 35.23%
2 Healthcare 25.2%
3 Consumer Discretionary 20.47%
4 Communication Services 8.05%
5 Financials 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBIO
401
Jade Biosciences
JBIO
$1.48B
-7
Closed -$4K
BDTX icon
402
Black Diamond Therapeutics
BDTX
$121M
-341
Closed -$1K
BOLT icon
403
Bolt Biotherapeutics
BOLT
$6.63M
-18
Closed -$1K
BVS icon
404
Bioventus
BVS
$1.17B
-577
Closed -$4K
CABA icon
405
Cabaletta Bio
CABA
$465M
-272
Closed
CADL icon
406
Candel Therapeutics
CADL
$783M
-271
Closed -$1K
CARM
407
DELISTED
Carisma Therapeutics
CARM
-93
Closed -$1K
CGEN icon
408
Compugen
CGEN
$236M
-811
Closed -$1K
CLLS
409
Cellectis
CLLS
$296M
-168
Closed
CLSD
410
DELISTED
Clearside Biomedical
CLSD
-38
Closed -$1K
CNTB
411
Connect Biopharma Holdings
CNTB
$147M
-397
Closed -$1K
CRIS icon
412
Curis
CRIS
$3.49M
-2
Closed -$1K
CRVS icon
413
Corvus Pharmaceuticals
CRVS
$1.27B
-436
Closed
CTMX icon
414
CytomX Therapeutics
CTMX
$760M
-617
Closed -$1K
DNTH icon
415
Dianthus Therapeutics
DNTH
$6.29B
-34
Closed -$1K
DTIL icon
416
Precision BioSciences
DTIL
$205M
-35
Closed -$1K
ERNA icon
417
Eterna Therapeutics
ERNA
$5.16M
0
EYPT icon
418
EyePoint Inc
EYPT
$1.17B
-319
Closed -$3K
HBIO icon
419
Harvard Bioscience
HBIO
$27.8M
-39
Closed -$1K
HOWL icon
420
Werewolf Therapeutics
HOWL
$18.6M
-277
Closed -$1K
IMA
421
ImageneBio Inc
IMA
$68M
-28
Closed -$1K
IMUX icon
422
Immunic
IMUX
$217M
-29
Closed -$1K
JANX icon
423
Janux Therapeutics
JANX
$1.02B
-390
Closed -$5K
KALV
424
DELISTED
KalVista Pharmaceuticals
KALV
-230
Closed -$3K
KMDA icon
425
Kamada
KMDA
$397M
-419
Closed -$2K

Similar funds

China Universal Asset Management Company's Q4 2022 Portfolio in Review

As of Q4 2022, China Universal Asset Management Company held 513 positions worth $249M, up 4.7% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

China Universal Asset Management Company's Q4 2022 filing shows 48 new, 266 increased, 45 reduced and 120 closed positions. Its largest new stake was iQIYI: 2,418,500 shares worth $12.8M. The largest sale was Tesla, an estimated $5.6M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • China Universal Asset Management Company's largest Q4 2022 buy was iQIYI: 2,418,500 shares worth $12.8M.
  • China Universal Asset Management Company added most to Amazon in Q4 2022, an estimated $3.89M increase.
  • China Universal Asset Management Company's biggest Q4 2022 reduction was Tesla, cutting an estimated $5.6M.
  • China Universal Asset Management Company fully exited Sprott Physical Gold in Q4 2022, selling an estimated $2.3M.
  • China Universal Asset Management Company's ten largest holdings make up 35% of its $249M portfolio in Q4 2022.
  • China Universal Asset Management Company opened 48 new positions and closed 120 in Q4 2022.
  • China Universal Asset Management Company's portfolio value rose 4.7% quarter-over-quarter to $249M.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.